An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients

Agibalova T.V.; Nedobylskiy O.V.; Poplevchenkov K.N.; Sirotko I.I.; Shcherban A.V.; Tsarev S.A.

doi:https://doi.org/10.17116/jnevro20171176132-34

Agibalova T.V.

Natsional'nyĭ nauchnyĭ tsentr narkologii Minzdravsotsrazvitiia Rossii

Nedobylskiy O.V.

Federal Medical Research Center of Psychiatry and Narcology of Ministry of Health, Russian Federation, Moscow

Poplevchenkov K.N.

Natsional'nyĭ nauchnyĭ tsentr narkologii Minzdravsotsrazvitiia Rossii

Sirotko I.I.

Department of the organization of socially significant and high-tech medical care of the Ministry of Health of the Samara region, Samara, Russia

Shcherban A.V.

State budgetary health care institution Samara Regional Narcological Dispensary, Samara, Russia

Tsarev S.A.

State budgetary health care institution Samara Regional Narcological Dispensary, Samara, Russia

An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients

Authors:

Agibalova T.V., Nedobylskiy O.V., Poplevchenkov K.N., Sirotko I.I., Shcherban A.V., Tsarev S.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6): 32‑34

DOI: 10.17116/jnevro20171176132-34

Read: 1123 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Agibalova TV, Nedobylskiy OV, Poplevchenkov KN, Sirotko II, Shcherban AV, Tsarev SA. An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6):32‑34. (In Russ.)
https://doi.org/10.17116/jnevro20171176132-34

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Objective. To analyze outcomes of treatment in the «Point of soberness» program for opioid addicted patients (2015—2016 гг.). Material and methods. The results of treatment of 83 opioid addicted patients were analyzed. Seventy-four (89.16%) patients received treatment course of injections of extended-release naltrexone (from 4 to 6 injections), maintaining their participation in the outpatient medical rehabilitation program. Thirty-six (43.37%) patients completed a full course of injections of extended-release naltrexone. Results and conclusion. The high efficacy of complex treatment with naltrexone injections was demonstrated. 89% of patients achieved remission during the course of treatment.

Keywords:

patients with opioid dependence

prolonged-action injectable form of naltrexone

outpatient rehabilitation program

Authors:

Agibalova T.V.

Natsional'nyĭ nauchnyĭ tsentr narkologii Minzdravsotsrazvitiia Rossii

Nedobylskiy O.V.

Federal Medical Research Center of Psychiatry and Narcology of Ministry of Health, Russian Federation, Moscow

Poplevchenkov K.N.

Natsional'nyĭ nauchnyĭ tsentr narkologii Minzdravsotsrazvitiia Rossii

Sirotko I.I.

Department of the organization of socially significant and high-tech medical care of the Ministry of Health of the Samara region, Samara, Russia

Shcherban A.V.

State budgetary health care institution Samara Regional Narcological Dispensary, Samara, Russia

Tsarev S.A.

State budgetary health care institution Samara Regional Narcological Dispensary, Samara, Russia

Close metadata

References:

Agibalova TV, Nedobylskiy OV, Koryakin SA, Volskaya KV. Program for prevention of illegal drug use in Samara Region. Narcology. 2015;14:5:57-61. (In Russ.) .
Agibalova TV, Lyubchenko DA, Borisenko LN, Ermakova GA, Rodina IP, Nedobylskiy OV, Klimachev KK, Nechaikin NM. Long-term results of the program «Point of Sobriety» in patients with alcohol dependence in the Krasnodar region. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2015;115(4):24-27. (In Russ.) . https://doi.org/10.17116/jnevro20151154224-27
Krupitsky EV, Nunes W, Ling A, Illeperuma DR, Gastfriend Bi. Silverman. Injectable extended release naltrexon for opoid dependence: a double-blind, placebo-controlled, multicentre randomized trial. Lancet. 2011;377:1506-1513 . https://doi.org/10.1016/S0140-6736(11)60358-9